Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation

Goetghebuer, Tessa; Le Chenadec, Jerome; Haelterman, Edwige; Galli, Luisa; Dollfus, Catherine; Thorne, Claire; Judd, Ali; Keiser, Olivia; Ramos, Jose Tomas; Levy, Jack; Warszawski, Josiane; European Infant Collaboration, Group (2012). Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clinical infectious diseases, 54(6), pp. 878-81. Cary, N.C.: Oxford University Press 10.1093/cid/cir950

[img]
Preview
Text
Goetghebuer ClinInfectDis 2012.pdf - Published Version
Available under License Publisher holds Copyright.

Download (355kB) | Preview

The clinical benefit of antiretroviral therapy in infants is established. In this cohort collaboration, we compare immunological and virological response to treatment started before or after 3 months of age. Early initiation provides a better short-term response, although evolution after 12 months of age is similar in both groups.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Keiser, Olivia

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1058-4838

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:22

Last Modified:

05 Dec 2022 14:06

Publisher DOI:

10.1093/cid/cir950

PubMed ID:

22198788

Web of Science ID:

000300790900024

BORIS DOI:

10.7892/boris.7369

URI:

https://boris.unibe.ch/id/eprint/7369 (FactScience: 212582)

Actions (login required)

Edit item Edit item
Provide Feedback